KALA

KALA BIO, Inc. Common Stock
Data: 2026-01-30
$0.53
Price
-3.20%
Change
$20.6
52W High
$0.51
52W Low

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

Quick Stats
Jan 30, 2026

41.0

AI Score

HOLD

0.32

Volume Ratio

Next Earnings

13

+ve Days (30d)

16

-ve Days (30d)

KALA Stock Summary

Last updated Jan 30, 2026

KALA is currently trading at $0.53, positioned below its 200-day moving average of $4.53, suggesting bearish momentum. The stock has a 52-week range of $0.51 to $20.6.

Technical Analysis: The 50-day moving average stands at $0.69, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 39.634, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.106, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates KALA at 41.0/100 with a HOLD recommendation.

KALA (KALA BIO, Inc. Common Stock) Indicators

Last updated Jan 30, 2026

Indicator Value
RSI(14) 39.634
CMF (20) -0.106
ROC (10) -11.77
ADX (14) 27.863
Indicator Value
MACD (12,26,9) -0.032
AROONOSC (14) -64.286
WILLAMS %R (14) -90.0
MFI (14) 48.816
KALA Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

KALA Price vs Max Options Open Interest
KALA Max Change In Options Open Interest

KALA Options - Sort by Max open Interest (near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

KALA Daily Out of Money Options - Sort by Max open Interest (near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

KALA Daily In the Money Options - Sort by Max open Interest (near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

KALA Most Active Options by Volume(near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

KALA BIO, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

KALA Moving Averages Analysis

KALA (KALA BIO, Inc. Common Stock) Simple Moving Averages

Moving Averages are last updated Jan 30, 2026

Days MA
10 0.59
20 0.61
30 0.61
50 0.69
100 3.22
200 4.53

KALA Fundamental Analysis

P/E (Forward) 0
P/E (Trailing) --
Market Cap ($) 15.0 million
Earnings/Share ($) -5.64
Net Proft Margin (%) 0
Dividend/Share ($) --
EPS Estimate Current Year ($) -4.45
EPS Estimate Next Year ($) -0.53
WallStreet Target Price ($) 1.5
Most Recent Quarter